Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Haemonetics Corp. buy Raymond James

Start price
€57.00
07.02.25 / 50%
Target price
€111.41
07.02.26
Performance (%)
-15.09%
End price
€48.40
08.02.26
Summary
This prediction ended on 08.02.26 with a price of €48.40. The prediction for Haemonetics Corp. disappointed with a performance of -15.09%. Raymond_James has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Haemonetics Corp. 0.826% 0.826% -
iShares Core DAX® 1,43 % 2,63 % 12,46 %
iShares Nasdaq 100 1,89 % -0,46 % 1,25 %
iShares Nikkei 225® -1,62 % 11,10 % 27,38 %
iShares S&P 500 1,92 % 1,16 % 1,63 %

Comments by Raymond_James for this prediction

In the thread Haemonetics Corp. diskutieren
Prediction Buy
Perf. (%) -15.09%
Target price 111.412
Change
Ends at 07.02.26

Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Ratings data for HAE provided by MarketBeat

In the thread Trading Haemonetics Corp.
Prediction Buy
Perf. (%) -15.09%
Target price 111.412
Change
Ends at 07.02.26

Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

Current prediction by Raymond_James for Haemonetics Corp.

buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€60.00
09.05.25
€93.63
09.05.26
-15.00%
16.02.26